Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 7

    1.

    Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes.

    Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark A, Balasubramanyam A.

    J Clin Endocrinol Metab. 2003 Nov;88(11):5090-8.PMID: 14602731 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Expression of the vesicular inhibitory amino acid transporter in pancreatic islet cells: distribution of the transporter within rat islets.

    Chessler SD, Simonson WT, Sweet IR, Hammerle LP.

    Diabetes. 2002 Jun;51(6):1763-71.PMID: 12031963 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Preservation of enzyme activity and antigenicity after mutagenesis of the membrane anchoring domain of GAD65.

    Plesner A, Hampe CS, Daniels TL, Hammerle LP, Lernmark A.

    Autoimmunity. 2001;34(4):221-30.PMID: 11905848 [PubMed - indexed for MEDLINE]Related articles

    4.

    Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.

    Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Persson B, Lernmark A.

    J Autoimmun. 2002 Feb;18(1):49-53.PMID: 11869046 [PubMed - indexed for MEDLINE]Related articles

    5.

    Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding.

    Hampe CS, Hammerle LP, Falorni A, Robertson J, Lernmark A.

    FEBS Lett. 2001 Jan 19;488(3):185-9.PMID: 11163769 [PubMed - indexed for MEDLINE]Related articles

    6.

    A novel monoclonal antibody specific for the N-terminal end of GAD65.

    Hampe CS, Lundgren P, Daniels TL, Hammerle LP, Marcovina SM, Lernmark A.

    J Neuroimmunol. 2001 Feb 1;113(1):63-71.PMID: 11137577 [PubMed - indexed for MEDLINE]Related articles

    7.

    Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

    Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Törn C, Persson B, Lernmark A.

    J Clin Endocrinol Metab. 2000 Dec;85(12):4671-9.PMID: 11134126 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...